Susavion Biosciences Inc - Company Review
Susavion Biosciences Inc - Company ReviewSummary
Susavion Biosciences Inc (Susavion) is a biotechnology company that concentrates on the design of novel peptides for cancer immunotherapy. The company's portfolio of pipeline drug candidates includes svL4, sv6B, svH1C, svH1D, svC2 and sv6D. The company developed a MultiValent peptide mimetic (MVPM) technology platform to identify activators of the immune system to treat cancer and other diseases. Its lead product svL4, indicated against cancer, reduces the growth of melanoma tumors and lowers the regulatory T cells within tumors. The Company has collaborated with the other scientists at University of Patras and the California Department of Public Health for the research and development of a peptide that mimics the sugar sialic acid. Susavion is headquartered in Tempe, Arizona, the US.
This comprehensive company report of Susavion Biosciences Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.